Harmony Biosciences Holdings, Inc. HRMY
Updated: 16 Jun 2026
No signal published yet
We already track Harmony Biosciences Holdings and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Harmony Biosciences Holdings, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Harmony Biosciences Holdings free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On May 7, 2026, Harmony reported Q1 2026 revenue of $215.4 million, a 17% year-over-year increase, and reaffirmed its full-year revenue guidance of over $1 billion. In June 2026, the company presented its strategic vision at the Goldman Sachs Global Healthcare Conference and announced research presentations for the SLEEP 2026 annual meeting.
What Firelda Watch includes for Harmony Biosciences Holdings, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Harmony Biosciences Holdings, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Harmony Biosciences Holdings free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more